{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:22:37Z","timestamp":1786123357439,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>The objective of this study was to assess the efficacy and cost of Malignant Hyperthermia Association of the United States\u2013recommended methods for preparing Dr\u00e4ger Zeus anesthesia workstations (AWSs) for the malignant hyperthermia-susceptible patient.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      We studied washout profiles of sevoflurane, isoflurane, and desflurane in 3 Zeus AWS following 3 preparation methods. AWS was primed with 1.2 minimum alveolar concentration anesthetic for 2 hours using 2 L\/min fresh gas flow, 500 mL tidal volume, and 12\/min respiratory rate. Two phases of washout were performed: high flow (10 L\/min) until anesthetic concentration was &lt;5 parts per million (ppm) for 20 minutes and then low flow (3 L\/min) for 20 minutes to identify the rebound effect. Preparation methods are as follows: method 1 (M1), changing disposables (breathing circuit, soda lime, CO\n                      <jats:sub>2<\/jats:sub>\n                      line, and water traps); method 2 (M2), M1 plus replacing the breathing system with an autoclaved one; and method 3 (M3), M1 plus mounting 2 activated charcoal filters on respiratory limbs. Primary outcomes are as follows: time to obtain anesthetic concentration &lt;5 ppm in the high-flow phase, peak anesthetic concentrations in the low-flow phase, and for M3 only, peak anesthetic concentration after 70 minutes of low-flow phase, when activated charcoal filters are removed. Secondary outcomes are as follows: cost analysis of time and resources to obtain anesthetic concentration &lt;5 ppm in each method and a vapor-free Zeus AWS. Sensitivity analyses were performed using alternative assumptions regarding the costs and the malignant hyperthermia-susceptible caseload per year.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Primary outcomes were as follows: M3 instantaneously decreased anesthetic concentration to &lt;1 ppm with minimal impact of low-flow phase. M1 (median, 88 minutes; 95% confidence interval [CI], 69\u2013112 minutes) was greater than M2 (median, 11 minutes; 95% CI, 9\u201315 minutes). Means of peak rebound anesthetic concentrations in M1, M2, and M3 were 15, 6, and 1 ppm, respectively (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001). Anesthetic concentration increased 33-fold (95% CI, 21\u201350) after removing charcoal filters (from 0.7 to 20 ppm). The choice of anesthetic agents did not impact the results. Secondary outcomes were as follows: M3 was the lowest cost when the cost of lost operating room (OR) time due to washout was included, and M1 was the lowest cost when it was not included. When the cost of lost OR time due to washout was considered the estimated cost\/case of M3 was US $360 (M1, US $2670; M2, US $969; and a \u201cvapor-free\u201d Zeus AWS was US $930). The OR time and equipment costs represent the largest differentiators among the methods.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Institutions in which demand for OR time has exceeded capacity should consider M3, and institutions with surplus OR capacity should consider M1.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000003441","type":"journal-article","created":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T19:44:06Z","timestamp":1527709446000},"page":"74-83","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy of Malignant Hyperthermia Association of the United States\u2013Recommended Methods of Preparation for Malignant Hyperthermia-Susceptible Patients Using Dr\u00e4ger Zeus Anesthesia Workstations and Associated Costs"],"prefix":"10.1213","volume":"129","author":[{"given":"Victor Manuel","family":"Neira","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Perioperative Medicine and Pain, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Al Madhoun","sequence":"additional","affiliation":[{"name":"Department of Chemical and Biological Engineering, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamyar","family":"Ghaffari","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Children\u2019s Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Barrowman","sequence":"additional","affiliation":[{"name":"Research Institute, Children\u2019s Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Berrigan","sequence":"additional","affiliation":[{"name":"Research Methods Unit, Nova Scotia Health Authority, Centre for Clinical Research, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Splinter","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Children\u2019s Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230721","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1001\/jama.293.23.2918","article-title":"Malignant hyperthermia: update on susceptibility testing.","volume":"293","author":"Litman","year":"2005","journal-title":"JAMA"},{"key":"R2-20230721","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/ALN.0b013e3181ee2cb7","article-title":"Preparation of modern anesthesia workstations for malignant hyperthermia-susceptible patients: a review of past and present practice.","volume":"114","author":"Kim","year":"2011","journal-title":"Anesthesiology"},{"key":"R3-20230721","first-page":"S287","article-title":"The effect of trace halothane exposure on triggering malignant hyperthermia in susceptible swine.","volume":"82","author":"Maccani","year":"1996","journal-title":"Anesth Analg"},{"key":"R4-20230721","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s12630-009-9097-7","article-title":"Preparation of the Dr\u00e4ger Fabius GS workstation for malignant hyperthermia-susceptible patients.","volume":"56","author":"Whitty","year":"2009","journal-title":"Can J Anaesth"},{"key":"R5-20230721","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/BF03022831","article-title":"Preparation of the Dr\u00e4ger Primus anesthetic machine for malignant hyperthermia-susceptible patients.","volume":"53","author":"Prinzhausen","year":"2006","journal-title":"Can J Anaesth"},{"key":"R6-20230721","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00000542-200702000-00017","article-title":"Accelerating the washout of inhalational anesthetics from the Dr\u00e4ger Primus anesthetic workstation: effect of exchangeable internal components.","volume":"106","author":"Crawford","year":"2007","journal-title":"Anesthesiology"},{"key":"R7-20230721","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1213\/ANE.0b013e318213fad7","article-title":"Activated charcoal effectively removes inhaled anesthetics from modern anesthesia machines.","volume":"112","author":"Birgenheier","year":"2011","journal-title":"Anesth Analg"},{"key":"R9-20230721","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s12630-014-0168-z","article-title":"Volatile gas consumption after introduction of the Dr\u00e4ger Zeus\u00ae anesthesia machine.","volume":"61","author":"Lokoff","year":"2014","journal-title":"Can J Anaesth"},{"key":"R10-20230721","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1213\/ANE.0000000000000208","article-title":"The sevoflurane washout profile of seven recent anesthesia workstations for malignant hyperthermia-susceptible adults and infants: a bench test study.","volume":"119","author":"Cottron","year":"2014","journal-title":"Anesth Analg"},{"key":"R11-20230721","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/EJA.0b013e328351b521","article-title":"Preparation of the Drager Fabius CE and Drager Zeus anaesthetic machines for patients susceptible to malignant hyperthermia.","volume":"29","author":"Shanahan","year":"2012","journal-title":"Eur J Anaesthesiol"},{"key":"R15-20230721","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s12630-014-0200-3","article-title":"Effects of fresh gas flow, tidal volume, and charcoal filters on the washout of sevoflurane from the Datex Ohmeda (GE) Aisys, Aestiva\/5, and Excel 210 SE Anesthesia Workstations.","volume":"61","author":"Sabouri","year":"2014","journal-title":"Can J Anaesth"},{"key":"R17-20230721","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine.","volume":"316","author":"Sanders","year":"2016","journal-title":"JAMA"},{"key":"R18-20230721","doi-asserted-by":"crossref","first-page":"147","DOI":"10.7326\/0003-4819-113-2-147","article-title":"A clinician\u2019s guide to cost-effectiveness analysis.","volume":"113","author":"Detsky","year":"1990","journal-title":"Ann Intern Med"},{"key":"R19-20230721","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5489\/cuaj.09166","article-title":"A cost-analysis comparison of laparoscopic radical prostatectomy versus open radical prostatectomy: the McMaster Institute of Urology experience.","volume":"4","author":"Al-shaiji","year":"2010","journal-title":"Can Urol Assoc J"},{"key":"R20-20230721","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jvir.2010.01.014","article-title":"Cost-effectiveness analysis of implantable venous access device insertion using interventional radiologic versus conventional operating room methods in pediatric patients with cancer.","volume":"21","author":"Hancock-Howard","year":"2010","journal-title":"J Vasc Interv Radiol"},{"key":"R21-20230721","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1097\/PRS.0b013e3182131c6b","article-title":"The use of AlloDerm in postmastectomy alloplastic breast reconstruction: part II: a cost analysis.","volume":"127","author":"Jansen","year":"2011","journal-title":"Plast Reconstr Surg"},{"key":"R22-20230721","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jclinane.2010.02.003","article-title":"What does one minute of operating room time cost?","volume":"22","author":"Macario","year":"2010","journal-title":"J Clin Anesth"},{"key":"R23-20230721","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/0002-9378(95)90432-8","article-title":"Single-use versus reusable laparoscopic surgical instruments: a comparative cost analysis.","volume":"173","author":"Schaer","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"R25-20230721","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-0500-5-3","article-title":"Cost analysis of two anaesthetic machines: \u201cPrimus\u00ae\u201d and \u201cZeus\u00ae.\u201d","volume":"5","author":"Hinz","year":"2012","journal-title":"BMC Res Notes"},{"key":"R27-20230721","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/0310057X1404200110","article-title":"Clarifying the role of activated charcoal filters in preparing an anaesthetic workstation for malignant hyperthermia-susceptible patients.","volume":"42","author":"Bilmen","year":"2014","journal-title":"Anaesth Intensive Care"},{"key":"R28-20230721","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/hec.985","article-title":"Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra.","volume":"14","author":"Claxton","year":"2005","journal-title":"Health Econ"},{"key":"R29-20230721","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1213\/ane.0b013e31818874d3","article-title":"Preparation of the Dr\u00e4ger Fabius anesthesia machine for the malignant-hyperthermia susceptible patient.","volume":"107","author":"Gunter","year":"2008","journal-title":"Anesth Analg"},{"key":"R30-20230721","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/0310057X1204000315","article-title":"Preparation of Datex-Ohmeda Aestiva and Aisys anaesthetic machines for use in malignant hyperthermia susceptible patients.","volume":"40","author":"Jones","year":"2012","journal-title":"Anaesth Intensive Care"},{"key":"R31-20230721","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00000542-200608000-00004","article-title":"Are your hospital operating rooms \u201cefficient\u201d? A scoring system with eight performance indicators.","volume":"105","author":"Macario","year":"2006","journal-title":"Anesthesiology"},{"key":"R32-20230721","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1213\/01.ANE.0000082520.68800.79","article-title":"Use of operating room information system data to predict the impact of reducing turnover times on staffing costs.","volume":"97","author":"Dexter","year":"2003","journal-title":"Anesth Analg"},{"key":"R33-20230721","first-page":"189","article-title":"Delays in the operating room: signs of an imperfect system.","volume":"53","author":"Wong","year":"2010","journal-title":"Can J Surg"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000539-201907000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:19:48Z","timestamp":1786112388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201907000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000003441","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}